+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival



Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival



Journal of Vascular Surgery 52(1): 167-175



Vascular smooth muscle cells (SMCs) are exposed to fluid shear stress (FSS) after interventional procedures such as balloon-angioplasty. Whereas the effects of hemodynamic forces on endothelial cells are explored in detail, the influence of FSS on smooth muscle cell function is poorly characterized. Here, we investigated the effect of FSS on SMC gene expression and function. Laminar FSS of arterial level (14 dynes/cm(2)) was applied to SMC cultures for 24 hours in a parallel-plate flow chamber. The effect of FSS on gene expression was first screened with microarray technology, and results further verified by real time polymerase chain reaction (RT-PCR) and immunoblotting. Tissue factor pathway inhibitor-2 (TFPI-2) and caspase-3 protein expression was studied in the rat carotid artery after balloon-injury, and the effect of TFPI-2 on SMC DNA synthesis and apoptosis was examined in vitro. Microarrays identified TFPI-2 as one of the most differentially expressed gene by FSS in cultured SMCs (P < .001). Gene set enrichment analysis revealed significant regulation of genes linked to proliferation, apoptosis, and cell cycle regulation. TFPI-2 induction was confirmed by RT-PCR and immunoblotting demonstrating a more than 400-fold (P < .001) increase in TFPI-2 mRNA in SMCs exposed to FSS compared with static controls, and a consistent protein upregulation. Functionally, SMC proliferation was decreased by FSS (P < .001), and recombinant TFPI-2 was found to inhibit SMC proliferation (P < .001) and induce SMC apoptosis as indicated by activation of caspase-3 (P < .01). In vivo, TFPI-2 expression was found to be upregulated 5, 10, and 20 hours (P < .01) after rat carotid balloon injury, and immunohistochemistry demonstrated TFPI-2 protein in FSS-exposed luminal SMCs, co-localized with caspase-3 in the rat carotid neointima. FSS influenced gene expression associated with cell growth and apoptosis in cultured SMCs and strongly induced expression of TFPI-2 mRNA and protein. TFPI-2 was expressed in luminal, FSS-exposed SMCs together with caspase-3 in the rat carotid neointima after balloon injury. Functionally, TFPI-2 may play a role in vessel wall repair by regulating SMC proliferation and survival. Further studies are needed to elucidate the mechanisms by which TFPI-2 controls SMC function.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056592149

Download citation: RISBibTeXText

PMID: 20537494

DOI: 10.1016/j.jvs.2010.02.282


Related references

Shear stress as an inhibitor of vascular smooth muscle cell proliferation. Role of transforming growth factor-beta 1 and tissue-type plasminogen activator. Arteriosclerosis, Thrombosis, and Vascular Biology 17(8): 1512-1516, 1997

Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration. Thrombosis Research 128(2): 179-185, 2012

Tissue factor pathway inhibitor-2 induces proliferation and morphological change in vascular smooth muscle cells. Circulation 100(18 SUPPL ): I 708, Nov 2, 1999

Overexpression of tissue factor pathway inhibitor in aortic smooth muscle cells inhibits cell migration induced by tissue factor/factor VIIa complex. Thrombosis Research 94(6): 401-406, 1999

Tissue factor pathway inhibitor suppresses the growth of human vascular smooth muscle cells through regulating cell cycle. Molecular Biology Reports 38(7): 4771-4776, 2011

Shear stress diminishes the functional, but not the antigenic, expression of tissue factor by cultured vascular endothelial cells while augmenting the production of tissue factor pathway inhibitor. Blood 94(10 SUPPL 1 PART 1): 224a, Nov 15, 1999

Fluid shear stress-induced alignment of cultured vascular smooth muscle cells. Journal of Biomechanical Engineering 124(1): 37-43, 2002

Mechanisms of fluid shear stress-induced alignment in cultured vascular smooth muscle cells. FASEB Journal 13(5 PART 2): A1020, March 15, 1999

Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells. Journal of Biological Chemistry 274(9): 5379-5384, 1999

Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitor. Blood Coagulation & Fibrinolysis 13(5): 449-455, 2002

SIRT1 and Connexin40 Mediate the normal shear stress-induced inhibition of the proliferation of endothelial cells co-cultured with vascular smooth muscle cells. Cellular Physiology and Biochemistry 31(2-3): 389-399, 2013

Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thrombosis and Haemostasis 78(3): 1138-1141, 1997

Upregulation of tissue factor pathway inhibitor by basic fibroblast growth factor and serum in vascular smooth muscle cells. Blood 92(10 SUPPL 1 PART 1-2): 550A, Nov 15, 1998

Expression and regulation of tissue factor pathway inhibitor in arteries and vascular smooth muscle cells. Circulation 96(8 SUPPL ): I663, 10/21/97, 1997

Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells. Plos One 9(10): E109268-E109268, 2015